Recoxibright 90 mg 30 tablets

Tradename

Recoxibright

Recoxibright

Compound:

Each tablet contains:

Etoricoxib 90 mg

Auxiliary components:

Calcium hydrogen phosphate, Avicel, Aerosil, microcrystalline cellulose, sodium croscarmellose, magnesium stearate.

Properties

Etoricoxib, when taken orally at therapeutic concentrations, is a selective inhibitor of cyclooxygenase-2 (COX-2). In clinical pharmacology studies, etoricoxib inhibited COX-2 in a dose-dependent manner with no effect on COX-1 at daily doses up to 150 mg. Etoricoxib does not inhibit the synthesis of prostaglandins in the gastric mucosa and does not affect platelet function.

Indications

-treatment of chronic pain in the lower back;

— symptomatic therapy of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, pain and inflammation associated with acute gouty arthritis;

— short-term therapy of moderate and severe acute pain after dental surgery.

Dosage and administration

The drug is taken orally, regardless of the meal, with a small amount of water.

The drug should be used in the minimum effective dose for the shortest possible course.

— the daily dose for osteoarthritis should not exceed 60 mg;

Contraindications

Hypersensitivity to the active substance, any excipient of the drug;

— active peptic ulcer or gastrointestinal bleeding; patients who have experienced bronchospasm, acute rhinitis, nasal polyps, angioedema, urticaria or other allergic reactions after the use of acetylsalicylic acid or NSAIDs, including COX-2 inhibitors;

-During pregnancy and breastfeeding;

Side effects

Epigastric pain, nausea, vomiting, diarrhea,

dyspepsia, flatulence,

bloating, belching,